1)receptor-mediated受体介导
1.Developments on receptor-mediated gene transfer;受体介导的基因转移研究进展
2.Finally,the receptor-mediated cellular uptake of the polymeric nanoparticles is specifically introduced,and the perspectives of the cellular uptake study of the polymeric nanoparticles are suggested.最后重点介绍了用于受体介导细胞胞吞的聚合物纳米粒子体系,指出了目前研究工作中的不足及未来发展方向。
英文短句/例句
1.Folate receptor-mediated antitumor drugs叶酸受体介导的抗肿瘤药物研究进展
2.Nerve Growth Cone Guidance Mediated by G Protein-coupled Receptors;G蛋白耦联受体介导的神经生长锥导向
3.Signal Transduction Pathways Mediated by Growth Factor Receptor;生长因子受体介导的信号转导通路研究进展
4.A Novel Tie2 Receptor-Mediated Gene Delivery System;TIE2受体介导的靶向性非病毒载体的构建
5.Involvement of NMDA Receptors in Release of PRL,ACTH and Gonadotropins During Restraint in Male Rats;NMDA受体介导束缚应激时腺垂体激素分泌的调节
6.Effects of Monoclonal Antibody of NMDA Receptor on NMDA-activated Current in Acutely Isolated Rat Hippocampal Neurons;NMDA受体主亚基NR1单克隆抗体对NMDA受体介导电流的调制作用
7.Study on the Molecular Mechanism of P2X7 Receptor Mediates Activation and Apoptosis in Human HEK293 Cells;P2X7受体介导的HEK293细胞活化与凋亡机理研究
8.I_1-imidazoline Receptor Mediates the Modulation to Morphine Dependence by Agmatine;I_1-咪唑啉受体介导胍丁胺对吗啡依赖的调节
9.Receptor-mediated Apoptosis and Cell Cycle Specificity;膜受体介导的细胞凋亡与细胞周期特异性
10.Liver X Receptors Mediate Cholesterol Efflux in Mouse Glomerular Mesangial Cells;肝X受体介导肾小球系膜细胞胆固醇外流
11.Development of Estrogen Receptor Mediated Reporter Gene Assays;雌激素受体介导的报告基因试验方法的建立
12.The Role of P2X_3 Receptor on the Peripheral Sensitization in a Rat Model of Bone Cancer Pain;P2X_3受体介导骨癌痛痛觉敏化机制的研究
13.Studies on the Endocrine Disrupting Effects of Environmental Chemicals Acting Through Nuclear Receptors;核受体介导的环境化学物内分泌干扰效应研究
14.ADENOSINE A2A RECEPTOR MEDIATES RESERPINE-INDUCED DEPRESSION IN RATS;腺苷A2a受体介导利血平引起的行为性抑郁(英文)
15.Gene expression and cytokine secretion of dendritic cells exposed to different Toll-like receptor ligands不同Toll样受体介导的树突状细胞因子表达
16.The effect of spontaneous membrane curvature on receptor-mediated endocytosis自发曲率对受体介导的胞吞作用的影响
17.Rosiglitazone induces mature differentiation of HL-60 leukemia cells with mediation of PPARγ activation罗格列酮经PPARγ受体介导HL-60细胞成熟分化
18.Study on the P2X7 Mediates Morphological Changes and Receptor Expression in Microglial Cells;P2X7受体介导的小胶质细胞形态变化和受体表达的研究
相关短句/例句
Receptor-mediated-liposome受体介导脂质体
3)Ligand-receptor mediate配体受体介导
4)Receptor-mediated toxicity受体介导毒性
5)receptor-mediated endocytosis受体介导内吞
1.Association of receptor-mediated endocytosis and autophagy with apoptosis;受体介导内吞和自噬同凋亡的关系
6)receptor mediated property受体介导特性
延伸阅读
脉心导敏 ,脉导敏,英他佐明,麦新导明药物名称：吗多明英文名：Molsidomine别名： 吗导敏;吗多明;吗斯酮胺;脉心导敏 ,脉导敏,英他佐明,麦新导明外文名：Molsidomine 特点： 脉导敏是一种属于亚胺类化合物，其作用与硝酸盐相似。舌下含服1毫克，2～4分钟起作用，可阻止心绞痛发作。口服一次可持续6～7小时，剂量每天3次，每次2毫克。副作用包括头痛、头胀、脸部发热感等，但不多见。 适应症： 防治心绞痛的发作。 用量用法： 口服：１次１～２ｍｇ，１日２～３次，发作时舌下含服：１次２ｍｇ。喷雾吸入：每次揿吸１～２次（相当于本品０．２～０．４ｍｇ），每日次数酌定。 注意事项： 1.一般不良反应可有头痛、面部潮红、眩晕等，停药后可自行消失。 2.低血压、青光眼病人忌用。 规格： 片剂：每片１ｍｇ、２ｍｇ。 气雾剂：每瓶含４２ｍｇ（可揿吸２００次左右）。 类别：非选择性钙通道阻滞剂||防治心绞痛药
